Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 217 (5), 813-8

Cost of Major Surgery in the Sarcopenic Patient


Cost of Major Surgery in the Sarcopenic Patient

Kyle H Sheetz et al. J Am Coll Surg.


Background: Sarcopenia is associated with poor outcomes after major surgery. There are currently no data regarding the financial implications of providing care for these high-risk patients.

Study design: We identified 1,593 patients within the Michigan Surgical Quality Collaborative (MSQC) who underwent elective major general or vascular surgery at a single institution between 2006 and 2011. Patient sarcopenia, determined by lean psoas area (LPA), was derived from preoperative CT scans using validated analytic morphomic methods. Financial data including hospital revenue and direct costs were acquired for each patient through the hospital's finance department. Financial data were adjusted for patient and procedural factors using multiple linear regression methods, and Mann-Whitney U test was used for significance testing.

Results: After controlling for patient and procedural factors, decreasing LPA was independently associated with increasing payer costs ($6,989.17 per 1,000 mm(2) LPA, p < 0.001). The influence of LPA on payer costs increased to $26,988.41 per 1,000 mm(2) decrease in LPA (p < 0.001) in patients who experienced a postoperative complication. Further, the covariate-adjusted hospital margin decreased by $2,620 per 1,000 mm(2) decrease in LPA (p < 0.001) such that average negative margins were observed in the third of patients with the smallest LPA.

Conclusions: Sarcopenia is associated with high payer costs and negative margins after major surgery. Although postoperative complications are universally expensive to payers and providers, sarcopenic patients represent a uniquely costly patient demographic. Given that sarcopenia may be remediable, efforts to attenuate costs associated with major surgery should focus on targeted preoperative interventions to optimize these high risk patients for surgery.


Figure 1
Figure 1
Covariate adjusted payer costs. Sarcopenia is significantly associated with higher payer costs. After adjusting for patient and procedural covariates, patient costs varied nearly 3-fold across the observed range of lean psoas area.
Figure 2
Figure 2
Covariate adjusted payer costs. Patients were grouped in to tertiles of lean psoas area. Payer costs in sarcopenic patients were significantly higher that non-sarcopenic patients in those with zero, one, and multiple complications (*denotes significance, p<0.001 for all). Black bar, no complications; light gray bar, 1 complication; dark gray bar, multiple complications.
Figure 3
Figure 3
Distribution of total hospital costs. The percentage of hospital costs attributed to the sarcopenic tertile of patients is significantly higher than those incurred by average and non-sarcopenic patients.
Figure 4
Figure 4
Covariate adjusted hospital margin. Lean psoas area is associated with overall hospital margin. Sarcopenic patients represented an overall negative margin for the hospital.

Similar articles

  • One-year Postoperative Resource Utilization in Sarcopenic Patients
    PS Kirk et al. J Surg Res 199 (1), 51-5. PMID 25990695.
    The effects of sarcopenia on health care costs are concentrated in the immediate postoperative period. It may be appropriate to allocate additional resources to sarcopeni …
  • Implications of Sarcopenia in Major Surgery
    J Friedman et al. Nutr Clin Pract 30 (2), 175-9. PMID 25681482.
    Through analytic morphomics, we are able to quantify markers of sarcopenia and identify patients at risk for increased mortality and poor surgical outcomes. Early identif …
  • Analytic Morphomics, Core Muscle Size, and Surgical Outcomes
    MJ Englesbe et al. Ann Surg 256 (2), 255-61. PMID 22791101.
    Core muscle size is an independent and potentially important preoperative risk factor. The techniques used to assess preoperative CT scans, namely analytic morphomics, ma …
  • Sarcopenia Predicts Costs Among Patients Undergoing Major Abdominal Operations
    F Gani et al. Surgery 160 (5), 1162-1171. PMID 27302103.
    As measured by sarcopenia, patient frailty is inversely related to total hospital costs. Sarcopenia represents a novel tool for forecasting patient outcomes and operative …
  • Prognostic Value of Sarcopenia in Liver Surgery
    M Cornet et al. J Visc Surg 152 (5), 297-304. PMID 26476674. - Review
    Current knowledge indicates that malnutrition increases the rate of post-operative complications, particularly respiratory and infectious, after major surgery. Almost all …
See all similar articles

Cited by 11 PubMed Central articles

See all "Cited by" articles

Publication types